Hyperoxia enhances exercise performance in PAH and CTEPH: Randomized trial

Silvia Ulrich (Zürich, Switzerland), Silvia Ulrich, Elisabeth Hasler, Stéphanie Saxer, Michael Furian, Séverine Müller-Mottet, Stephan Keusch, Konrad Bloch

Source: International Congress 2016 – Clinic of pulmonary hypertension
Session: Clinic of pulmonary hypertension
Session type: Oral Presentation
Number: 264
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Silvia Ulrich (Zürich, Switzerland), Silvia Ulrich, Elisabeth Hasler, Stéphanie Saxer, Michael Furian, Séverine Müller-Mottet, Stephan Keusch, Konrad Bloch. Hyperoxia enhances exercise performance in PAH and CTEPH: Randomized trial. Eur Respir J 2016; 48: Suppl. 60, 264

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of hyperoxia on exercise performance in COPD: Randomized trial
Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease
Year: 2016


Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – A prospective, randomized, controlled trial
Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2016


Randomized, controlled, prospective multicenter study: Training improves peak oxygen consumption and hemodynamics in patients with chronic severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH
Year: 2014


Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with precapillary pulmonary hypertension and sleep disturbed breathing. Randomized, double-blind, cross-over trial
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Safety related to maximal cardiopulmonary exercise testing in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016


The effects of beta-blocker therapy on systolic and diastolic function in pulmonary arterial hypertension: A randomized controlled trial
Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH
Year: 2014


Open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH)
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016


Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Riociguat improves excessive exercise ventilation in patients with inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013


Patient perspectives on exercise training in pulmonary arterial hypertension (PAH)
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


Effect of apelin on cardiopulmonary performance during endurance exercise
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015


Exercise capacity in patients with Pulmonary Arterial Hypertension: multicentric analysis of aerobic capacity and survival
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020


Atorvastatin in Pulmonary Arterial Hypertension (APATH) study
Source: Eur Respir J 2012; 40: 67-74
Year: 2012



An open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Effect of long-term oxygen therapy on exercise capacity and quality of life in exercise-desaturating patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomized-sham-controlled cross-over trial
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017

Impact of noninvasive ventilation on exercise tolerance in subjects with heart failure: Randomized and controlled clinical trial
Source: International Congress 2014 – Key factors that ensure noninvasive ventilation success
Year: 2014

Evolution of patients with Pulmonary Arterial Hypertension (PAH) six months after an exercise training program
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019


Beta-blocker therapy nor hyperoxic breathing lowers ventilatory drive in pulmonary arterial hypertension patients
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014


Clinical usefulness of end-tidal CO2 profiles during rapidly-incremental exercise in patients with idiopathic and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Clinical exercise physiology
Year: 2013

Effects of 12-week exercise training-related rehabilitation on exertional dyspnoea in patients with idiopathic pulmonary arterial hypertension
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015